The Jewels in Our Genes Study - an African American Family Study of Breast Cancer

The research team is studying why some African American families have multiple cases of breast cancer.

This study will help to better understand if there are undiscovered genes unique to African Americans that may predict early breast cancer risk.

Breast cancer survivors AND their relatives who are also breast cancer survivors are being recruited to the study.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Neoplasms Neoplasms by Site Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year–100 year

Sex eligibility

Female

Study type

Observational

Primary location

University at Buffalo

Buffalo, New York, 14214-8001, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Black/African American
Ever diagnosed with breast cancer
Have at least one living blood relative ever diagnosed with breast cancer, who is also willing to participate
Live in the U.S.

Exclusion criteria

Tested positive for BRCA mutations

Treatment and study plan

Primary outcomes

breast cancer

Sponsors and collaborators

Lead sponsor

University at Buffalo

Other

Collaborators

Susan G. Komen Breast Cancer Foundation

Registry information

Official study title

Search for Novel Breast Cancer Susceptibility Genes in Pedigrees of African Ancestry

Important dates

Study start: 2010
Primary completion: 2012
Study completion: 2012
First posted: Jun 27, 2011
Registry last updated: May 11, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed